BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15479836)

  • 1. Identification of a negative regulatory element in the Epstein-Barr virus Zta transactivation domain that is regulated by the cell cycle control factors c-Myc and E2F1.
    Lin Z; Yin Q; Flemington E
    J Virol; 2004 Nov; 78(21):11962-71. PubMed ID: 15479836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.
    Schelcher C; Valencia S; Delecluse HJ; Hicks M; Sinclair AJ
    J Virol; 2005 Nov; 79(21):13822-8. PubMed ID: 16227304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation.
    Deng Z; Chen CJ; Zerby D; Delecluse HJ; Lieberman PM
    J Virol; 2001 Nov; 75(21):10334-47. PubMed ID: 11581402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
    Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK
    Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle.
    Guo Q; Qian L; Guo L; Shi M; Chen C; Lv X; Yu M; Hu M; Jiang G; Guo N
    Mol Immunol; 2010 May; 47(9):1783-92. PubMed ID: 20338640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.
    Wang P; Day L; Dheekollu J; Lieberman PM
    J Virol; 2005 Nov; 79(21):13298-309. PubMed ID: 16227252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.
    Rodriguez A; Armstrong M; Dwyer D; Flemington E
    J Virol; 1999 Nov; 73(11):9029-38. PubMed ID: 10516009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference.
    Chang Y; Chang SS; Lee HH; Doong SL; Takada K; Tsai CH
    J Gen Virol; 2004 Jun; 85(Pt 6):1371-1379. PubMed ID: 15166418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.
    Wang P; Day L; Lieberman PM
    J Virol; 2006 Nov; 80(22):10942-9. PubMed ID: 16971443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.
    Wiedmer A; Wang P; Zhou J; Rennekamp AJ; Tiranti V; Zeviani M; Lieberman PM
    J Virol; 2008 May; 82(9):4647-55. PubMed ID: 18305033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents.
    Rodriguez A; Jung EJ; Flemington EK
    J Virol; 2001 May; 75(10):4482-9. PubMed ID: 11312318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
    Chang Y; Lee HH; Chen YT; Lu J; Wu SY; Chen CW; Takada K; Tsai CH
    J Virol; 2006 Aug; 80(15):7748-55. PubMed ID: 16840354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus.
    Zerby D; Chen CJ; Poon E; Lee D; Shiekhattar R; Lieberman PM
    Mol Cell Biol; 1999 Mar; 19(3):1617-26. PubMed ID: 10022850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.
    Cayrol C; Flemington EK
    EMBO J; 1996 Jun; 15(11):2748-59. PubMed ID: 8654372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.
    Gao Z; Krithivas A; Finan JE; Semmes OJ; Zhou S; Wang Y; Hayward SD
    J Virol; 1998 Nov; 72(11):8559-67. PubMed ID: 9765394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.
    Flemington EK; Lytle JP; Cayrol C; Borras AM; Speck SH
    Mol Cell Biol; 1994 May; 14(5):3041-52. PubMed ID: 8164660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain.
    Flemington EK; Borras AM; Lytle JP; Speck SH
    J Virol; 1992 Feb; 66(2):922-9. PubMed ID: 1309920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.